MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
GNLX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Genelux (GNLX) Ownership - Who owns Genelux?

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
2625 Townsgate Road
Phone
+1 805 267-9889
Employees
26
Web
https://www.genelux.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
130.93M
P/E Ratio
N/A
Total Cash
26.21M
Projected Growth
N/A
Total Debt
2.5M
Revenue
8K
Risk (Beta)
1.62
Dividend Yield
N/A
Total Cash/Share
0.58
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
GNLX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for GNLX
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
2625 Townsgate Road
Phone
+1 805 267-9889
Employees
26
Web
https://www.genelux.com